Market Place
Sourcing Support
Stevanato Group to Present at Upcoming Investor Conferences
11 Nov 2024 //
BUSINESSWIRE
Stevanato Group Reports Financial Results for the Q3of 2024
05 Nov 2024 //
BUSINESSWIRE
Stevanato Group To Report Q3 2024 Results On Nov 5
22 Oct 2024 //
BUSINESSWIRE
Stevanato To Introduce 10mL Vertiva® Delivery System At CPHI
01 Oct 2024 //
BUSINESSWIRE
Stevanato Group Introduces Large-Volume Vertiva On-Body System
01 Oct 2024 //
CONTRACT PHARMA
Stevanato, Gerresheimer, SCHOTT Form Alliance for RTU
27 Sep 2024 //
CONTRACT PHARMA
Stevanato, Gerresheimer, SCHOTT Pharma Form Alliance
26 Sep 2024 //
BUSINESSWIRE
Stevanato Group to Present at Upcoming Investor Conferences
29 Aug 2024 //
BUSINESSWIRE
Stevanato Group Reports Financial Results for the Second Quarter of 2024
06 Aug 2024 //
BUSINESSWIRE
Stevanato Group To Report Q2 2024 Results On August 6
25 Jul 2024 //
BUSINESSWIRE
Stevanato Unveils New Plant For Pre-Sterilized Syringes And Cartridges
30 May 2024 //
BUSINESSWIRE
Stevanato Group: Franco Stevanato Appointed CEO, Succeeding Franco Moro
28 May 2024 //
BUSINESSWIRE
Stevanato Group Announces Results of Annual General Meeting
24 May 2024 //
BUSINESSWIRE
Stevanato Group to Present at Upcoming Investor Conferences
23 May 2024 //
BUSINESSWIRE
Stevanato Group Reports Financial Results for the First Quarter of 2024
09 May 2024 //
BUSINESSWIRE
Stevanato To Present At BofA Healthcare Conference
01 May 2024 //
BUSINESSWIRE
Stevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024
25 Apr 2024 //
BUSINESSWIRE
Stevanato Group appoints Ugo Gay as Chief Operations Officer
04 Apr 2024 //
BUSINESSWIRE
Stevanato Group Announces Closing of Upsized PO of Ordinary Shares
26 Mar 2024 //
BUSINESSWIRE
Stevanato Group Announces Pricing of Upsized Public Offering of Ordinary Shares
21 Mar 2024 //
BUSINESSWIRE
Stevanato Group Announces Public Offering of Ordinary Shares
20 Mar 2024 //
BUSINESSWIRE
Stevanato Group Delivers Double-Digit Revenue Growth in Fiscal Year 2023
07 Mar 2024 //
BUSINESSWIRE
Stevanato Group to Report Fourth Quarter and Year End 2023 Financial Results
22 Feb 2024 //
BUSINESSWIRE
Stevanato Group Launches EZ-fill® Kit and Laboratory Fill and Finish Service
24 Jan 2024 //
BUSINESSWIRE
Stevanato Group to Present at the 42nd Annual J.P. Morgan Healthcare Conference
03 Jan 2024 //
BUSINESSWIRE
Stevanato`s Mavis Combi Inspection Machine Selected as Innovation Award Winner
16 Nov 2023 //
BUSINESSWIRE
Stevanato Group to Present at the Jefferies London Healthcare Conference
09 Nov 2023 //
BUSINESSWIRE
Stevanato Group Reports Third Quarter 2023 Financial Results
31 Oct 2023 //
BUSINESSWIRE
Stevanato to Report Third Quarter 2023 Financial Results on October 31, 2023
17 Oct 2023 //
BUSINESSWIRE
Stevanato Group Announces Voting Results from its Extraordinary General Meeting
05 Oct 2023 //
BUSINESSWIRE
Stevanato to Livestream Inaugural Capital Markets Day on September 27, 2023
19 Sep 2023 //
BUSINESSWIRE
Stevanato Group Reports Second Quarter 2023 Financial Results
28 Jul 2023 //
BUSINESSWIRE
Stevanato Group to Report Second Quarter 2023 Financial Results on July 28, 2023
14 Jul 2023 //
BUSINESSWIRE
Stevanato Group Presents Vertiva™, a Versatile On-Body Delivery System Platform
12 Jun 2023 //
BUSINESSWIRE
Stevanato Group Announces Change in Ex-Dividend Date for its Dividend
07 Jun 2023 //
BUSINESSWIRE
Stevanato Group to Present at Upcoming Investor Conferences
24 May 2023 //
BUSINESSWIRE
Stevanato Group to Present at BofA Securities Healthcare Conference
02 May 2023 //
BUSINESSWIRE
Stevanato Group to Report First Quarter 2023 Financial Results on May 4, 2023
17 Apr 2023 //
BUSINESSWIRE
Stevanato Group Collaborates with Recipharm to Develop Pre-fillable Syringes
16 Mar 2023 //
BUSINESSWIRE
Stevanato Group Secures €130 Million ESG-Linked Financing From BNL BNP Paribas
08 Mar 2023 //
BUSINESSWIRE
Stevanato Group Secures €130 Million in ESG-Linked Financing
08 Mar 2023 //
CONTRACT PHARMA
Stevanato Group Reports Fourth Quarter and Fiscal Year 2022 Financial Results
02 Mar 2023 //
BUSINESSWIRE
Stevanato to Report Fourth Quarter 2022 Financial Results on March 2, 2023
16 Feb 2023 //
BUSINESSWIRE
Stevanato Group, Transcoject Partner on Pre-Fillable Syringe Polymer Options
25 Jan 2023 //
CONTRACT PHARMA
Stevanato Collaborates with Transcoject to Provide Syringe Polymer Options
24 Jan 2023 //
BUSINESSWIRE
Stevanato Group Reports Third Quarter 2022 Financial Results
08 Nov 2022 //
BUSINESSWIRE
Stevanato Group and Gerresheimer AG Unveil EZ-fill Smart
02 Nov 2022 //
CLINICALTRIALSARENA
Stevanato Group and Gerresheimer AG Present EZ-fill Smart™
01 Nov 2022 //
BUSINESSWIRE
Stevanato Group and DWK Life Sciences Sign Distribution Agreement
27 Oct 2022 //
BUSINESSWIRE
Stevanato Group and DWK Life Sciences Enter Non-Exclusive Agreement
27 Oct 2022 //
CONTRACTPHARMA
Stevanato Group to Report Third Quarter 2022 Financial Results
24 Oct 2022 //
BUSINESSWIRE
Stevanato & IL Group Partner to Improve Safe Processing of Hazardous Injectables
14 Oct 2022 //
CONTRACTPHARMA
Stevanato, Gerresheimer ally to make ready-to-use vial platform
13 Sep 2022 //
FIERCEPHARMA
Stevanato Group to Present at Upcoming Investor Conference
09 Sep 2022 //
BUSINESSWIRE
Stevanato Group & Gerresheimer AG Jointly Develop High-End Ready-To-Use Solution
07 Sep 2022 //
CONTRACTPHARMA
Stevanato & Gerresheimer to Collaborate on the Development Vial Platform
07 Sep 2022 //
BUSINESSWIRE
Stevanato Group Reports Second Quarter 2022 Financial Results
04 Aug 2022 //
BUSINESSWIRE
Stevanato Group to Report Q2 2022 Financial Results on August 4, 2022
22 Jul 2022 //
BUSINESSWIRE
Stevanato Group Releases Sustainability Report 2021
13 Jun 2022 //
BUSINESSWIRE
